Copyright Reports & Markets. All rights reserved.

Global Human Prothrombin Complex Market Insights and Forecast to 2027

Buy now

1 Study Coverage

  • 1.1 Human Prothrombin Complex Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Human Prothrombin Complex Market Size Growth Rate by Type
    • 1.4.2 500 IU/Vial
    • 1.4.3 600 IU/Vial
    • 1.2.4 1000 IU/Vial
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Human Prothrombin Complex Market Size Growth Rate by Application
    • 1.3.2 Hemophilia B
    • 1.3.3 Vitamin K Deficiency
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Human Prothrombin Complex Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Human Prothrombin Complex Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Human Prothrombin Complex Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Human Prothrombin Complex Regions by Sales
    • 2.4.1 Global Top Human Prothrombin Complex Regions by Sales (2016-2021)
    • 2.4.2 Global Top Human Prothrombin Complex Regions by Sales (2022-2027)
  • 2.5 Global Top Human Prothrombin Complex Regions by Revenue
    • 2.5.1 Global Top Human Prothrombin Complex Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Human Prothrombin Complex Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Human Prothrombin Complex Sales by Manufacturers
    • 3.1.1 Global Top Human Prothrombin Complex Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top Human Prothrombin Complex Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by Human Prothrombin Complex Sales in 2020
  • 3.2 Global Human Prothrombin Complex Revenue by Manufacturers
    • 3.2.1 Global Top Human Prothrombin Complex Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top Human Prothrombin Complex Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by Human Prothrombin Complex Revenue in 2020
  • 3.3 Global Human Prothrombin Complex Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Human Prothrombin Complex Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Human Prothrombin Complex Sales by Type
    • 4.1.1 Global Human Prothrombin Complex Historical Sales by Type (2016-2021)
    • 4.1.2 Global Human Prothrombin Complex Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Human Prothrombin Complex Sales Market Share by Type (2016-2027)
  • 4.2 Global Human Prothrombin Complex Revenue by Type
    • 4.2.1 Global Human Prothrombin Complex Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Human Prothrombin Complex Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Human Prothrombin Complex Revenue Market Share by Type (2016-2027)
  • 4.3 Global Human Prothrombin Complex Price by Type
    • 4.3.1 Global Human Prothrombin Complex Price by Type (2016-2021)
    • 4.3.2 Global Human Prothrombin Complex Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global Human Prothrombin Complex Sales by Application
    • 5.1.1 Global Human Prothrombin Complex Historical Sales by Application (2016-2021)
    • 5.1.2 Global Human Prothrombin Complex Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Human Prothrombin Complex Sales Market Share by Application (2016-2027)
  • 5.2 Global Human Prothrombin Complex Revenue by Application
    • 5.2.1 Global Human Prothrombin Complex Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Human Prothrombin Complex Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Human Prothrombin Complex Revenue Market Share by Application (2016-2027)
  • 5.3 Global Human Prothrombin Complex Price by Application
    • 5.3.1 Global Human Prothrombin Complex Price by Application (2016-2021)
    • 5.3.2 Global Human Prothrombin Complex Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America Human Prothrombin Complex Market Size by Type
    • 6.1.1 North America Human Prothrombin Complex Sales by Type (2016-2027)
    • 6.1.2 North America Human Prothrombin Complex Revenue by Type (2016-2027)
  • 6.2 North America Human Prothrombin Complex Market Size by Application
    • 6.2.1 North America Human Prothrombin Complex Sales by Application (2016-2027)
    • 6.2.2 North America Human Prothrombin Complex Revenue by Application (2016-2027)
  • 6.3 North America Human Prothrombin Complex Market Size by Country
    • 6.3.1 North America Human Prothrombin Complex Sales by Country (2016-2027)
    • 6.3.2 North America Human Prothrombin Complex Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Human Prothrombin Complex Market Size by Type
    • 7.1.1 Europe Human Prothrombin Complex Sales by Type (2017-2027)
    • 7.1.2 Europe Human Prothrombin Complex Revenue by Type (2017-2027)
  • 7.2 Europe Human Prothrombin Complex Market Size by Application
    • 7.2.1 Europe Human Prothrombin Complex Sales by Application (2017-2027)
    • 7.2.2 Europe Human Prothrombin Complex Revenue by Application (2017-2027)
  • 7.3 Europe Human Prothrombin Complex Market Size by Country
    • 7.3.1 Europe Human Prothrombin Complex Sales by Country (2017-2027)
    • 7.3.2 Europe Human Prothrombin Complex Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Human Prothrombin Complex Market Size by Type
    • 8.1.1 Asia Pacific Human Prothrombin Complex Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific Human Prothrombin Complex Revenue by Type (2018-2027)
  • 8.2 Asia Pacific Human Prothrombin Complex Market Size by Application
    • 8.2.1 Asia Pacific Human Prothrombin Complex Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific Human Prothrombin Complex Revenue by Application (2018-2027)
  • 8.3 Asia Pacific Human Prothrombin Complex Market Size by Region
    • 8.3.1 Asia Pacific Human Prothrombin Complex Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific Human Prothrombin Complex Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Human Prothrombin Complex Market Size by Type
    • 9.1.1 Latin America Human Prothrombin Complex Sales by Type (2019-2027)
    • 9.1.2 Latin America Human Prothrombin Complex Revenue by Type (2019-2027)
  • 9.2 Latin America Human Prothrombin Complex Market Size by Application
    • 9.2.1 Latin America Human Prothrombin Complex Sales by Application (2019-2027)
    • 9.2.2 Latin America Human Prothrombin Complex Revenue by Application (2019-2027)
  • 9.3 Latin America Human Prothrombin Complex Market Size by Country
    • 9.3.1 Latin America Human Prothrombin Complex Sales by Country (2019-2027)
    • 9.3.2 Latin America Human Prothrombin Complex Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa Human Prothrombin Complex Market Size by Type
    • 6.1.1 Middle East and Africa Human Prothrombin Complex Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa Human Prothrombin Complex Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa Human Prothrombin Complex Market Size by Application
    • 6.2.1 Middle East and Africa Human Prothrombin Complex Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa Human Prothrombin Complex Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa Human Prothrombin Complex Market Size by Country
    • 6.3.1 Middle East and Africa Human Prothrombin Complex Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa Human Prothrombin Complex Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 U.A.E

11 Company Profiles

  • 11.1 Takeda
    • 11.1.1 Takeda Corporation Information
    • 11.1.2 Takeda Overview
    • 11.1.3 Takeda Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Takeda Human Prothrombin Complex Product Description
    • 11.1.5 Takeda Related Developments
  • 11.2 CSL
    • 11.2.1 CSL Corporation Information
    • 11.2.2 CSL Overview
    • 11.2.3 CSL Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 CSL Human Prothrombin Complex Product Description
    • 11.2.5 CSL Related Developments
  • 11.3 Grifols
    • 11.3.1 Grifols Corporation Information
    • 11.3.2 Grifols Overview
    • 11.3.3 Grifols Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 Grifols Human Prothrombin Complex Product Description
    • 11.3.5 Grifols Related Developments
  • 11.4 Octapharma
    • 11.4.1 Octapharma Corporation Information
    • 11.4.2 Octapharma Overview
    • 11.4.3 Octapharma Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 Octapharma Human Prothrombin Complex Product Description
    • 11.4.5 Octapharma Related Developments
  • 11.5 Hualan Biological
    • 11.5.1 Hualan Biological Corporation Information
    • 11.5.2 Hualan Biological Overview
    • 11.5.3 Hualan Biological Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 Hualan Biological Human Prothrombin Complex Product Description
    • 11.5.5 Hualan Biological Related Developments
  • 11.6 Meheco Xinxing Pharma
    • 11.6.1 Meheco Xinxing Pharma Corporation Information
    • 11.6.2 Meheco Xinxing Pharma Overview
    • 11.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Product Description
    • 11.6.5 Meheco Xinxing Pharma Related Developments
  • 11.1 Takeda
    • 11.1.1 Takeda Corporation Information
    • 11.1.2 Takeda Overview
    • 11.1.3 Takeda Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Takeda Human Prothrombin Complex Product Description
    • 11.1.5 Takeda Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Human Prothrombin Complex Value Chain Analysis
  • 12.2 Human Prothrombin Complex Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Human Prothrombin Complex Production Mode & Process
  • 12.4 Human Prothrombin Complex Sales and Marketing
    • 12.4.1 Human Prothrombin Complex Sales Channels
    • 12.4.2 Human Prothrombin Complex Distributors
  • 12.5 Human Prothrombin Complex Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Human Prothrombin Complex Industry Trends
  • 13.2 Human Prothrombin Complex Market Drivers
  • 13.3 Human Prothrombin Complex Market Challenges
  • 13.4 Human Prothrombin Complex Market Restraints

14 Key Findings in The Global Human Prothrombin Complex Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Human Prothrombin Complex market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Prothrombin Complex market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

    Segment by Type
    500 IU/Vial
    600 IU/Vial
    1000 IU/Vial
    Others

    Segment by Application
    Hemophilia B
    Vitamin K Deficiency
    Others

    By Company
    Takeda
    CSL
    Grifols
    Octapharma
    Hualan Biological
    Meheco Xinxing Pharma

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia

    Buy now